Today is Monday, April 13, 2026.
The Early Bird Index today is 79.09.
New to this newsletter? Sign up here
PRESENTED BY CASH APP
3 money habits teens can start building now
With a Cash App Card, teens can take their first steps toward independence with a secure debit card. They’ll learn how to spend, save, and manage money, all with your guidance and oversight to help them get started.
1. Learn to spend responsibly
A debit card gives them a safe way to practice managing money under your supervision. It gives you the opportunity to teach them how to make smart spending choices.
2. Start saving for their goals
Setting goals can help them see how saving a little at a time can help them reach their short-term and long-term goals.
3. Manage their own money
Whether they get paid with direct deposit or use Cash App to get allowance or gifts, they get real experience with money.
Cash App is a financial services platform, not a bank. Banking services provided by Cash App’s bank partner(s). Prepaid debit cards issued by Sutton Bank, Member FDIC. Cash App Visa® Debit Flex Cards issued by Sutton Bank, Member FDIC, and The Bancorp Bank, N.A., pursuant to a license from Visa U.S.A. Inc. See terms and conditions for the Sutton prepaid card (https://cash.app/legal/us/en-us/card-agreement), Sutton debit flex card (https://cash. app/legal/us/en-us/debit-flex-card-agreement-sutton), and Bancorp debit flex card (https:// cash.app/legal/us/en-us/debit-flex-card-agreement-bancorp).
GSK's Big Cancer Drug Gamble 🎲
Pharmaceutical company GSK $GSK ( ▼ 0.26% ) is so thrilled with recent cancer drug results that it is reportedly taking a big swing at new trials.
Details: Bloomberg reported on Sunday that GSK is planning five simultaneous late-stage trials for its cancer drug mocertatug rezetecan (or Mo-Rez for short), hoping that it will be a big hit for the company. The late-stage trials include three studies in ovarian cancer and two in endometrial cancer.
Also: On Sunday, GSK revealed that Mo-Rez achieved phase I objective responsive rates of 62% in ovarian cancer and 67% in endometrial cancer.
Background: The reported decision to have five simultaneous late-stage trials is a bit of a gamble for GSK, which is trying to take more risks to boost its pipeline and remain competitive against other pharma rivals.
Stock Price: GSK’s stock is up 17.29% in 2026.
Early Bird’s Nest Egg Gains: Five simultaneous late-stage trials signal that GSK is trying to turn Mo-Rez into a meaningful growth driver, not just a single speculative asset.
For investors, that raises both the upside — a potential blockbuster in oncology — and the risk, since late-stage trials can still fail or disappoint.
Final Thoughts: It could potentially cost GSK tens of millions of dollars for each late-stage trial.
Notables
Notable Earnings Today: Goldman Sachs (NYSE: GS), Fastenal (Nasdaq: FAST), FB Financial (NYSE: FBK), Sify Technologies (Nasdaq: SIFY).
Notable IPOs Today: Paloma Acquisition Corp I Class A Ordinary Shares (Nasdaq: PALO), Abony Acquisition Corp. I Class A Ordinary Share (Nasdaq: AACO), Nicola Mining Inc. American Depositary Shares (Nasdaq: NICM).
Notable Equity Crowdfunding Campaigns Ending Today: Puredrive Energy (Crowdcube), Recyclus Group (Crowdcube).
Notable Economic Events Today: Existing Home Sales (10:00 a.m. ET).
Cardano's Bad Week Continues
Most major cryptocurrency prices rebounded slightly this past week, except Cardano $ADA ( ▼ 0.63% ). It is down about 3% in the past week, including a 2% dive on Sunday.
Details: Cardano’s issue seems more structural than event-driven. It has slower ecosystem momentum, weaker sentiment, and a market that keeps favoring faster-moving major cryptos instead.
Final Thoughts: Cardano is down about 28%in 2026.
JBS Reaches Labor Deal
The U.S. unit for the meat processing enterprise JBS $JBS ( ▼ 0.54% ) reached a new collective bargaining agreement with a group of beef processing plant workers in Colorado who were on strike for about three weeks.
Details: The new deal, which runs through April 2028, includes higher wages and workplace changes.
Final Thoughts: Shares of JBS are up 29.20% in 2026.
Trends to Watch
Handy Reality: Bitcoin may be forming a base at $65,000 as 'paper hands' have been flushed out (CoinDesk)
Powerful AI: AI Is Using So Much Energy That Computing Firepower Is Running Out (Wall Street Journal)
Can’t Block This Bad News: Oil prices rise after Trump threatens to block passage through Strait of Hormuz (CNN)
Rough Flashback: Lessons learned in ‘70s have made the US and world economies less vulnerable to oil shocks (Associated Press)
Beginning This Week: April’s stock-market rebound is about to face its first major test as earnings season swings into gear (MarketWatch)
Thank you for reading!
Forward to a friend and tell them to sign up here.
Pick winning stocks: Upgrade to Early Bird Prime.
Be social: Like our Facebook page and follow us on Twitter.
Want more investing tips? Listen to the podcast.
Show Your Support: Buy Me a Coffee.
Questions or comments? Hit reply to reach out.
The contents of Early Bird are intended for informational and entertainment purposes only. They do not constitute trade or investment recommendations, and they are not financial or legal advice. Readers are encouraged to consult licensed professionals for personalized guidance regarding their financial or legal situations.
